You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

telaglenastat

Showing 1 - 15 of 15
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in United

Recruiting
  • Advanced Lung Non-Small Cell Carcinoma
  • +2 more
  • Birmingham, Alabama
  • +10 more
Jan 25, 2023

Leptomeningeal Tumor, Metastatic Lung Non-Small Cell Carcinoma, Metastatic Malignant Tumor in the Brain Trial in United States

Recruiting
  • Leptomeningeal Neoplasm
  • +6 more
  • Duarte, California
  • +6 more
Dec 29, 2022

Solid Tumors, NSCLC, CRC Trial in United States (Telaglenestat (CB-839), Palbociclib Oral Capsule or Tablet [Ibrance])

Completed
  • Solid Tumors
  • +3 more
  • Telaglenestat (CB-839)
  • Palbociclib Oral Capsule or Tablet [Ibrance]
  • Santa Monica, California
  • +9 more
Sep 14, 2022

Astrocytoma, IDH-Mutant, Grade 2, Astrocytoma, IDH-Mutant, Grade 3 Trial in United States (other, radiation, drug)

Active, not recruiting
  • Astrocytoma, IDH-Mutant, Grade 2
  • Astrocytoma, IDH-Mutant, Grade 3
  • Questionnaire Administration
  • +3 more
  • Phoenix, Arizona
  • +24 more
Dec 7, 2022

Cardiac Safety Trial in Belfast (telaglenastat, telaglenastat , moxifloxicin)

Completed
  • Cardiac Safety
  • telaglenastat
  • +2 more
  • Belfast, Ireland, United Kingdom
    Celerion
Mar 8, 2021

Prostate Cancer Metastatic Trial in Boston (Telaglenastat, Talazoparib)

Not yet recruiting
  • Prostate Cancer Metastatic
  • Boston, Massachusetts
    Massachusetts General Hospital
Mar 27, 2021

Solid Tumor, Clear Cell Renal Cell Carcinoma, TNBC - Triple-Negative Breast Cancer Trial in United States (CB-839, Talazoparib)

Terminated
Has Results
  • Solid Tumor
  • +6 more
  • Birmingham, Alabama
  • +8 more
Feb 16, 2022

Drug Interaction Trial in Brisbane (Telaglenastat, Famotidine, Placebo for famotidine)

Completed
  • Drug Interaction
  • Telaglenastat
  • +2 more
  • Brisbane, Queensland, Australia
    Nucleus Network Brisbane Clinic (formerly Q-Pharm)
Mar 8, 2021

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, NF1 Mutation Positive Malignant Peripheral Nerve Sheath Tumor

Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • +3 more
  • Pharmacodynamic Study
  • Telaglenastat Hydrochloride
  • Birmingham, Alabama
  • +30 more
Sep 1, 2022

Triple Negative Breast Cancer, TNBC - Triple-Negative Breast Cancer Trial in United States (Paclitaxel, CB-839)

Completed
Has Results
  • Triple Negative Breast Cancer
  • TNBC - Triple-Negative Breast Cancer
  • Birmingham, Alabama
  • +24 more
Sep 19, 2022

NSCLC, Non-squamous Non-small-cell Lung Cancer, Non-Squamous Non-Small Cell Tumor of Lung Trial in United States (drug,

Terminated
  • Non-Small Cell Lung Cancer
  • +5 more
  • Telaglenastat
  • +7 more
  • Birmingham, Alabama
  • +101 more
Mar 8, 2022

Clear Cell Renal Cell Carcinoma (ccRCC), Melanoma, NSCLC (NSCLC) Trial in United States (CB-839, Nivolumab)

Completed
  • Clear Cell Renal Cell Carcinoma (ccRCC)
  • +2 more
  • Scottsdale, Arizona
  • +16 more
Aug 16, 2021

Advanced Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma Trial in Worldwide (CB-839, Cabozantinib, Placebo)

Completed
  • Advanced Renal Cell Carcinoma
  • Metastatic Renal Cell Carcinoma
  • Birmingham, Alabama
  • +132 more
Aug 18, 2021

Clear Cell Renal Cell Carcinoma Trial in United States (Placebo, CB-839, everolimus)

Completed
  • Clear Cell Renal Cell Carcinoma
  • Placebo
  • +2 more
  • Tucson, Arizona
  • +37 more
Aug 16, 2021

NSCLC, Non-squamous Non-small-cell Lung Cancer, Non-Squamous Non-Small Cell Tumor of Lung Trial in United States (Liquid Biopsy

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • +5 more
  • Liquid Biopsy NGS Test
  • Daphne, Alabama
  • +62 more
Nov 5, 2021